Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02434705 · ClinicalTrials.gov registry record
Food Antigen in Eosinophilic Esophagitis
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 72
- Enrollment target
NCT02434705: Completed study, sponsored by Mayo Clinic.
NCT02434705 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02434705 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The relationship or effect of food antigen (wheat based soy sauce) in eosinophilic esophagitis. It is believed that when food antigens are exposed to the esophageal tissue it starts an chronic allergy-based inflammation. This will be analyzed with the esophageal biopsies and the mucosal impedance probe.
Primary Outcome
Cryosectioning of the frozen esophageal tissue will then be done for immunofluorescent staining to determine the distribution/localization of different cells and dietary proteins We will use anti-gliadin (Biorbyt catalog # orb157160)and anti-soy (LifeSpan Biosciences Catalog # LS-C132165-100)antibodies against cell surface markers as well as dietary proteins/peptides tagged with different fluorochromes to achieve this.
Interventions
- OTHER Antigen (wheat base soy sauce) spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2015-04-01 |
| Est. Completion | 2023-12-08 |
What the finished NCT02434705 record still lists
NCT02434705 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Antigen (wheat base soy sauce) spray is the first listed.
NCT02434705 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02434705 about?
NCT02434705 is a clinical study titled "Food Antigen in Eosinophilic Esophagitis". The relationship or effect of food antigen (wheat based soy sauce) in eosinophilic esophagitis. It is believed that when food antigens are exposed to the esophageal tissue it starts an chronic allergy-based inflammation. This will be analyzed with the esophageal biopsies and the mucosal impedance pr...
What is the current status of trial NCT02434705?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2015-04-01. Estimated completion is 2023-12-08.
What interventions are being tested in trial NCT02434705?
The interventions under investigation include: Antigen (wheat base soy sauce) spray (OTHER).
Who is sponsoring clinical trial NCT02434705?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI